Vaxfectin: a versatile adjuvant for plasmid DNA- and protein-based vaccines (Q37813689)

23 August 2017

1 reference

title

Vaxfectin: a versatile adjuvant for plasmid DNA- and protein-based vaccines (English)

1 reference

23 August 2017

1 reference

3

0 references

author name string

Sean M Sullivan

1

1 reference

23 August 2017

John Doukas

2

1 reference

23 August 2017

Larry Smith

4

1 reference

23 August 2017

Alain Rolland

5

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 December 2010

1 reference

Expert Opinion on Drug Delivery

23 August 2017

1 reference

23 August 2017

7

1 reference

23 August 2017

1433-1446

1 reference

23 August 2017

12

1 reference

Genetic immunization is a simple method for eliciting an immune response

23 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Vaxfectin, a cationic lipid-based adjuvant for protein-based influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Liposomal delivery of CTL epitopes to dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Vaxfectin enhances immunogenicity and protective efficacy of P. yoelii circumsporozoite DNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Vaxfectin enhances both antibody and in vitro T cell responses to each component of a 5-gene Plasmodium falciparum plasmid DNA vaccine mixture administered at low doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Vaccination with polymerase chain reaction-generated linear expression cassettes protects mice against lethal influenza A challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Toxicological Safety Evaluation of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar Despite Differing Plasmid Backbones or Gene-Inserts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

II. Cationic lipid-formulated plasmid DNA-based Bacillus anthracis vaccine: evaluation of plasmid DNA persistence and integration potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

I. Poloxamer-formulated plasmid DNA-based human cytomegalovirus vaccine: evaluation of plasmid DNA biodistribution/persistence and integration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Potential DNA vaccine integration into host cell genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Preparing for a possible pandemic: influenza A/H5N1 vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

21 January 2018

TLRs and innate immunity

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Improved tuberculosis DNA vaccines by formulation in cationic lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Enhancing effect of vaxfectin on the ability of a Japanese encephalitis DNA vaccine to induce neutralizing antibody in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Sustained protective rabies neutralizing antibody titers after administration of cationic lipid-formulated pDNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Salivary gland delivery of pDNA-cationic lipoplexes elicits systemic immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Comparison of the immunological memory after DNA vaccination and protein vaccination against anthrax in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.538047

10.1517/17425247.2010.538047

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference